Skip to main content
logo
International Stem Cell Corporation (ISCO)
OTCMKTS · Delayed Price · Currency is USD
0.1351
0.00 (0.00%)
Apr 15, 2026, 2:01 PM EST

International Stem Cell Revenue

In the year 2025, International Stem Cell had annual revenue of $9.10M with 0.17% growth. International Stem Cell had revenue of $2.16M in the quarter ending December 31, 2025, a decrease of -11.90%.

Revenue
9.10M
Revenue Growth
+0.17%
P/S Ratio
0.12
Revenue / Employee
275.76K
Employees
33
Market Cap
1.08M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.10M15.00K0.17%
Dec 31, 20249.09M1.30M16.64%
Dec 31, 20237.79M-391.00K-4.78%
Dec 31, 20228.18M1.00M13.99%
Dec 31, 20217.18M48.00K0.67%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
LakeShore Biopharma84.75M
Carisma Therapeutics52.63M
Evofem Biosciences20.18M
Clearside Biomedical3.33M
Lyra Therapeutics398.00K
Iterum Therapeutics390.00K
Eastgate Biotech137.64K
Enzolytics46.59K
Revenue Rankings

International Stem Cell News

More News